Advertisement

Topics

Latest "Important Process Fueling Harmful Algal Blooms Investigated Canadian" News Stories

22:23 EST 18th December 2018 | BioPortfolio

Here are the most relevant search results for "Important Process Fueling Harmful Algal Blooms Investigated Canadian" found in our extensive news archives from over 250 global news sources.

More Information about Important Process Fueling Harmful Algal Blooms Investigated Canadian on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Important Process Fueling Harmful Algal Blooms Investigated Canadian for you to read. Along with our medical data and news we also list Important Process Fueling Harmful Algal Blooms Investigated Canadian Clinical Trials, which are updated daily. BioPortfolio also has a large database of Important Process Fueling Harmful Algal Blooms Investigated Canadian Companies for you to search.

Showing "Important Process Fueling Harmful Algal Blooms Investigated Canadian" News Articles 1–25 of 21,000+

Tuesday 18th December 2018

Crown Bioscience Inc 6554 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryCrown Bioscience Inc Crown Bioscience is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, oncology services, and metabolic disease services, among others. Crown Bioscience provides its preclinical...


Jiangsu Jumpcan Pharmaceutical Group Co Ltd 600566 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryJiangsu Jumpcan Pharmaceutical Group Co Ltd Jiangsu Jumpcan Pharma is a developer, manufacturer and distributor of Chinese traditional medicine, Western medicine, daily use chemicals and healthcare products. The company offers its products in various therapeutic segments such as detoxification, digestive system, pediatric, respiratory system, nervous system, antiinfection, cardiovascular, n...

Helsinn Healthcare SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryHelsinn Healthcare SA Helsinn Healthcare, a subsidiary of Helsinn Holding SA is a cancer care company that offers oncology products and therapies. The company offers products in therapeutic areas of pain and inflammation, cancer care and gastroenterology. Its products comprise Aloxi, Gelclair, Akynzeo, Nimesulide, KleanPrep and laxaclear. The company offers research and development programs...


Study by @IndianaUniv researchers “raises important questions about the relationship between the primary ingredients in cannabis and their effect on the eye." http://ow.ly/uyVr30n21yL 

Study by @IndianaUniv researchers “raises important questions about the relationship between the primary ingredients in cannabis and their effect on the eye." http://ow.ly/uyVr30n21yL 

Rhinovirus Infections Global Clinical Trials Review, H2, 2018 [Report Updated: 31072018] Prices from USD $2125

Rhinovirus Infections Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Rhinovirus Infections Global Clinical Trials Review, H2, 2018" provides an overview of Rhinovirus Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Rhinovirus Infections. Report includes an overview of trial numbers and their average enrol...

Alfa Wassermann SpA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryAlfa Wassermann SpA Alfa Wassermann, a subsidiary of AlfaSigma SpA is a pharmaceutical company which produces and distributes drugs for human health. The company provides new discoveries in medicine, biology and genomics. Alfa Wassermann finds solutions for paradox treatment. The company offers self meditation products for sore throat, headaches, and muscle and joint pain treatments. It als...

Canadian Cancer Trials Group Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryCanadian Cancer Trials Group CCTG, is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The company conducts trials for the development of new drugs and therapies for the treatment of various diseases. It provides services for cancer therapy, supportive care and prevention. CCTG offers clinical trials for prod...

Martindale Pharmaceuticals Ltd Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryMartindale Pharmaceuticals Ltd Martindale, a subsidiary of Cardinal Health Inc is a pharmaceutical company that offers formulations. The company provides hospitalinitiated medicines in emergency medicine and differentiated products in complex neurological conditions,opioid addiction and paediatric cardiology. It focuses on emergency care drugs, hospital initiated medicines, opioid addiction...

Granulomatosis with Polyangiitis Wegener's Granulomatosis Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2125

Granulomatosis with Polyangiitis Wegener's Granulomatosis Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Granulomatosis with Polyangiitis Wegener's Granulomatosis Global Clinical Trials Review, H2, 2018" provides an overview of Granulomatosis with Polyangiitis Wegener's Granulomatosis clinical trials scenario. This report provides top line data relating to the cl...

Cellular Dynamics International Inc Medical Equipment Deals and Alliances Profile [Report Updated: 14122018] Prices from USD $250

SummaryCellular Dynamics International Inc CDI, a subsidiary of Fujifilm Holdings Corp is a biotechnology company that develops and manufactures fully functioning human cells in industrial quantities to precise specifications. The company's products include icell cardiomyocytes, icell endothelial cells, icell hepatocytes, icell neurons, icell prototypes and mycell products. It also offers Mycell p...

Takeda Announces Listing of American Depositary Shares on the New York Stock Exchange

ADSs Will Trade Under the Ticker Symbol “TAK” NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) today announced that the listing ...

Stago Releases a New Educational Webinar on Validation and Verification of Clinical Coagulation Assays and Instrumentation in a Multisite Hospital Network

On January 15, a new webinar by Jana Gausman, MT(ASCP), will be released at Stago EdVantage Virtual University. Attendees will learn about the responsibility of the laboratory during the validation and verification process for newly acquired instrumentation, along with strategies for ensuring continuous quality of laboratory testing results on a daily basis. Coagulation testing applications will b...

Canadian #cannabis alliance of @tilray and @Sandoz_Global goes global: http://ow.ly/N0A430n21is 

Canadian #cannabis alliance of @tilray and @Sandoz_Global goes global: http://ow.ly/N0A430n21is 

Journal Club December 2018

The topic for the December Journal C

Scynexis Inc SCYX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryScynexis Inc Scynexis is a pharmaceutical company that discovers, develops and commercializes novel antiinfective for various therapeutic needs. The company provides pipeline products such as SCY078, is used for invasive fungal infections; SCY635, is used for the treatment of Hepatitis C HCV; SCYX7158, is used for sleeping sickness; SCY641, is for human health, among others. Its SCY078 is a...

Anavex Life Sciences Corp AVXL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAnavex Life Sciences Corp Anavex is a clinicalstage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system CNS diseases, pain and various types of cancer. The company's target indications include Alzheimer's disease, Parkinson's disease, Rett syndrome, epilepsy, neu...

Computerized genetic-design tools are helping to automate the process by which researchers design complex genetic circuits that can program cells. https://go.nature.com/2GlMoO5 

Computerized genetic-design tools are helping to automate the process by which researchers design complex genetic circuits that can program cells. https://go.nature.com/2GlMoO5 

$SURF - man, dosing is so important. Tough luck for them.

$SURF - man, dosing is so important. Tough luck for them.

Cyprotex Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 11122018] Prices from USD $250

SummaryCyprotex Ltd Cyprotex, a subsidiary of Evotec AG is a provider of ADMETox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company's core capabilities include high quality mechanistic toxicology, in vitro ADME screening services, and high content toxicology screening services, including propriet...

Definiens AG Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryDefiniens AG Definiens, a subsidiary of AstraZeneca Plc, is a healthcare technology company that offers image analysis and data mining solutions. The company offers products such as tissue studio, developer, image miner, server, architect and viewer, among others. Its services include consulting and planning services, image analysis solution services, integration and deployment services and...

Editas Medicine Inc EDIT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryEditas Medicine Inc Editas Medicine formerly Gengine Inc, is a discovery stage biotechnology company that develops genome level treatments for rare diseases. The company is developing a proprietary genome editing platform based on its inlicensed clustered regularly interspaced short palindromic repeats CRISPR technology. The company's preclinical pipeline spans investigational candidates fo...

UnitedHealth Group cuts purchase price for DaVita assets by $560M

The companies said the new price was due to a decline in the financial status of the medical group, along with a desire t

Leadiant Biosciences Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryLeadiant Biosciences Inc Leadiant Biosciences, formerly SigmaTau Pharmaceuticals Inc, a subsidiary of Leadiant Biosciences SpA, is a pharmaceutical company that discovers and develops novel medicines. The company provides products such as abelcet, adagen, carnitor, cystaran, depocyt, matulane and revcovi, among others. It also offers services including patient support, discovery and develop...

Recipharm AB RECI B Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryRecipharm AB Recipharm is a contract development and manufacturing organization CDMO that offers manufacturing, and development and technology services. The organization's manufacturing segment provides contract manufacturing of pharmaceuticals such as semisolids, and oral liquids, solid dose, sterile products, besides clinical trial materials including APIs and other drugs. Recipharm's dev...

First-Ever Human Health and Animal Health Drug Development Collaboration to Prevent Cancer Recurrence

Ethos Veterinary Health and Vuja De Sciences to utilize novel cellular assays of cancer metastasis and integration of pet dogs with cancer to empower innovative metastasis-focused drug development collaboration. WOBURN, Mass. and HOBOKEN, N.J. (PRWEB) December 18, 2018 Ethos Veterinary Health (“Ethos”) and Vuja De Sciences (“Vuja De”) have entered into a Memorandum of Understanding to ide...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks